Abstract
Genetic counselling (GC) and genetic testing (GT) form an important component of multidisciplinary management of breast and ovarian cancer. There are many barriers to effective GC and testing for hereditary breast and ovarian cancers and more so in developing countries.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
